Syed Ali Aamir Rizvi is Chief Medical Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 185,000 shares of PSTX, which is worth approximately $503,200. The most recent transaction as insider was on Apr 01, 2024, when has been sold 185,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K
0% 3M change
n/a 12M change
Total Value Held $503,200

Syed Ali-aamir Rizvi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
BUY
Grant, award, or other acquisition
-
185,000 Added 50.0%
185,000 Common Stock

Also insider at

CRBU
Caribou Biosciences, Inc. Healthcare
SAR

Syed Ali Aamir Rizvi

Chief Medical Officer
Berkeley, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX